The role of embolization in musculoskeletal pain management, treatment of haemorrhoidal bleeding and lymphatic interventions were among the highlights of a special session titled The Embolization Vanguard at the Global Embolization Symposium and Technologies (GEST 2016 US, 5‰ÛÒ8 May, New York, USA) meeting.
Bruno Sangro, director of the Liver Unit and co-director, of the HPB Oncology Area, Clinca Universidad de Navarra, Pamplona, Spain, delivered the European Conference on Interventional Oncology (ECIO) Honorary Lecture on the topic ‰ÛÏIntra-arterial treatment of hepatocellular carcinoma (HCC) at the dawn of systemic therapy‰Û.
What if physicians could perform an optical biopsy? Further, what if during a cryoablation procedure, an interventional radiologist can actually see what happens during the procedure at a cellular level in real time? A new tool, Cellvizio (Mauna Kea) does just that.
Many malpractice lawsuits are filed because of an unexpected, adverse outcome. This underscores the importance of communication between physicians and patients. Informed consent is paramount, and an excellent patient-physician relationship deters litigation because people generally do not sue people they like, write Brian Funaki and Hector Ferral.
Lombard Medical, has announced the 30-day clinical results from 57 patients that were implanted with the Altura endograft system.
Sirtex has announced that Discovery Health, a South African private health insurer, has agreed to reimburse SIR-Spheres Y-90 resin microspheres for the treatment of all forms of inoperable liver tumours.
Merit has announced that it has signed a distribution deal with Piolax Medical Devices of Yokohama, Japan for a product known in Japan as the Labyrinth Noah micro guidewire.
The results from a small prospective, randomised single-centre trial, the PREMIERE trial, show that in patients with unresectable hepatocellular carcinoma, there is a significantly longer time to progression with yttrium-90 (Y-90) radioembolization than with conventional transarterial chemoembolization (cTACE).
While most radiologists probably do not view a biopsy as being the most exciting or technically challenging procedure within our repertoire, it may be time to give the image-guided biopsy a second look, writes Alda Tam.
BTG has entered into an agreement to acquire Galil Medical, a provider of cryoablation products for the treatment and palliative care of kidney and other cancers.
Following a 2014 multicentre survey of members aiming to identify any gaps in the status of interventional radiology staffing, the Society of Interventional Radiology (SIR) has published 11 new recommendations to help centres meet the growing demand for services.
Auris Surgical Robotics and Hansen Medical today announced that they have signed a definitive merger agreement under which Auris will acquire Hansen Medical for US$4.00 per share in cash, or a total equity value of approximately US$80 million.
Ethicon has announced a definitive agreement to acquire NeuWave Medical. Financial terms of the transaction, which is expected to close during the second quarter of 2016, have not been disclosed.
Scott Trerotola, Stanley Baum Professor and chief, Vascular and Interventional Radiology, University of Pennsylvania Medical Center, Philadelphia, USA, delivered the Dr Charles T Dotter Lecture at the 2016 Society of Interventional Radiology (SIR) annual meeting in Vancouver, Canada. An inventor of both devices and procedures, he speaks to Interventional News about his belief in evidence-based medicine and the triumphs and travails of being a physician inventor.
A pioneering technique significantly reduces phantom pain emanating from the site of amputated limbs, according to findings presented at the Society of Interventional Radiology‰Ûªs 2016 Annual Scientific Meeting (2‰ÛÒ7 April, Vancouver, Canada).
Charles E Ray Jr, an interventional radiologist, and professor and head of the department of radiology at the College of Medicine at the University of Illinois at Chicago, assumed the office of president of the Society of Interventional Radiology during the society‰Ûªs Annual Scientific Meeting (2‰ÛÒ7 April, Vancouver, Canada).
The interventional radiology procedure for men with enlarged prostates decreases the number of times they wake to urinate in the night, according to research presented at the Society of Interventional Radiology‰Ûªs 2016 Annual Scientific Meeting (2‰ÛÒ7 April, Vancouver, Canada.)
A safe, new, minimally invasive treatment, developed by interventional radiologists, led to sustained weight loss in severely obese people, according to research presented at the Society of Interventional Radiology‰Ûªs 2016 Annual Scientific Meeting.
Women who underwent embolization for the treatment of uterine fibroids experienced improved sexual desire and a higher overall quality of life. The research, part of a French multicentre study, presented at the Society of Interventional Radiology‰Ûªs Annual Scientific Meeting, also found the vast majority of women treated with the procedure sustained improvement for more than a year.
BTG has announced plans to initiate the TARGET (TheraSphere advanced dosimetry retrospective global study evaluation in hepatocellular carcinoma treatment) study.
In order to fully capitalise on the potential of advances in materials, drugs, biologics, sensing, informatics, guidance, manufacturing processes and marketing, an organised collaborative approach to innovation is required, writes John Kaufman.
LC Bead Lumi is the first and only, commercially available, radiopaque embolic bead in the USA and has potential to revolutionise the treatment of hypervascular tumours and arteriovenous malformations, a press release from BTG says.
The UK National Institute for Health and Care Excellence (NICE) has issued a new Medtech Innovation Briefing stating that National Health Service doctors and commissioners may consider SIR-Spheres Y-90 resin microspheres as an alternative to standard therapy with transarterial chemoembolization or sorafenib in the treatment of patients with inoperable primary liver cancer.
Select sessions from the SIR 2016 Annual Scientific Meeting will be webcast live from 3‰ÛÒ5 April 2016 on VIRtual SIR 2016.
Merit Medical Systems has announced its schedule of activity for the upcoming Society of Interventional Radiology (SIR) Meeting, being held in Vancouver, Canada, April 2-7 2016. During the meeting, Merit will present educational opportunities. The company will also showcase several new products, including the HeRO graft, which Merit recently acquired from Cryolife.
Merit Medical has announced receiving notification of substantial equivalence from the US FDA for the Corvocet Biopsy System, which is intended for use in obtaining core biopsy samples from the liver, kidney, prostate, breast, lung and various other soft tissue tumours.
Lantern is a low profile, high flow microcatheter designed to assist in the delivery of diagnostic agents, such as contrast media, and therapeutic devices, such as occlusion coils, to the peripheral vasculature.
A study has found that radiofrequency ablation to treat liver metastases in patients with colorectal cancer, induces antitumour immune responses in human samples of primary colon tumour.
The Mount Sinai Hospital, New York City, USA has become the first in the country to offer radiopaque bead treatment for liver cancer patients. The minimally invasive treatment using the M1 Lumi Bead loaded with doxorubicin, is now available for patients with inoperable and difficult-to-treat liver cancer.
A study presented at the Symposium on Clinical Oncology (CIO, Hollywood, USA) noted that the hepatitis C virus is a cause of significant morbidity and mortality in the USA. However, the study findings report that treatment regimens have improved in recent years.
A study presented at the European Congress of Radiology (2‰ÛÒ6 March, Vienna, Austria) set out to investigate any procedural or anatomical factors that might affect the technical outcome of prostatic artery embolization.
"As interventionalists, we have attempted to make the scalpel obsolete by employing technology to treat patients non-operatively. Today, there is revolution occurring‰ÛÓtheranostics,‰Û said Alan Matsumoto, during his delivery of the Charles J Tegtmeyer Lecture at the International Symposium on Endovascular Therapy (ISET, Hollywood, USA) 2016.
The Netherlands Healthcare Institute approved reimbursement with the therapy for patients with colorectal liver metastases who have failed prior treatment, and based its decision on the clinical evidence of the efficacy and safety of SIR-Spheres (Sirtex) Y-90 resin microspheres for treating this patient group, a press release from Sirtex says.
AngioDynamics has signed an agreement with Merz North America, US affiliates of the global Merz Pharma Group. AngioDynamics is to serve as the exclusive distributor of the Asclera polidocanol injection within the US vein market.
Jens Ricke, professor of Radiology at the University of Magdeburg, has announced that the palliative cohort of the pan-European SORAMIC study he co-directs with Peter Malfertheiner has reached its enrolment target of 420 patients with unresectable hepatocellular carcinoma.
Ultrasound-guided radiofrequency ablation results in significant volume reduction for benign thyroid...
Two studies presented at the European Congress of Radiology (2‰ÛÒ6 March, Vienna, Austria) have found that radiofrequency ablation could have a role in the treatment of thyroid nodules.
Two studies presented at The International Symposium on Endovascular Therapy (6‰ÛÒ10 February 2016, Hollywood, USA) found that there was inadequate information from manufacturers about many of their protective garments. This means that informed decisions are hard to make regarding the radiation protection offered by these garments.
Attention should be focused on patients with iliofemoral and caval deep vein thrombosis and the balance should always be struck between the risk of bleeding and the long-term risk of post thrombotic syndrome, writes Stephen Black.
The Gore Excluder iliac branch endoprosthesis has become the first off-the-shelf aortic branch to be approved by the US Food and Drug Administration (FDA), according to a company release.
A recent presentation shed light on catheter-directed intra-arterial thrombolysis for frostbite. The investigators urged interventional radiologists to become familiar with the current management of frostbite injury and play a role in the multidisciplinary trauma team.
Acute mesenteric ischaemia can be successfully treated with endovascular therapy such as balloon angioplasty, according to research from the University of Eastern Finland.
The addition of SIR-Spheres (Sirtex) to chemotherapy has been shown to significantly prolong progression-free survival in the liver among patients with non-resectable liver-dominant or liver-only colorectal cancer in the SIRFLOX study.
Percutaneous radiologic gastrostomy is a classic interventional radiology procedure. As patient populations and preferences change, and as newer devices and approaches are established, it is essential for interventional radiologists to evolve individual and institutional conventions and adopt data-driven practices that minimise risks on a patient-tailored basis, writes Rahul Sheth.
Boston Scientific has received CE mark for the Eluvia drug-eluting vascular stent, and is to begin commercialisation of the product immediately. The company has also received Investigational Device Exemption to asses the Eluvia vs the Zilver PTX (Cook Medical).
Research presented in February at the Symposium on Clinical Interventional Oncology (CIO), held in conjunction with International Symposium on Endovascular Therapy (ISET), in Hollywood, USA, provides a clear shot in the arm for chemoembolization that uses doxorubicin and ethiodised oil over the triple-drug version.
The device was used as part of a robotic transarterial chemoembolization procedure, which was completed by Ripal Gandhi at Miami Cardiac & Vascular Institute, Miami, USA.
The final results from a phase 2 randomised trial, published online in the Journal of Clinical Oncology on 1 February, find no benefit from using doxorubicin-eluting beads (LC Bead, BTG) over embolic microspheres that do not elute a drug (Bead Block, BTG).
The role of interventional radiology in the management of severely traumatised patients began three to four decades ago with the embolization of the internal iliac arteries for massive pelvic bleeding. Over time, interventional radiology has progressively taken on a principal role in management of trauma patients, writes Jaime Tisnado.
With the Magellan robotic catheter eKit, physicians will now have robotic control of third party microcatheters through the existing Magellan Robotic Catheter 6F architecture. This added ability has the potential to help reduce procedure times and radiation exposure.
The treatment targeted a hypervascular tumour with the goal of blocking blood flow to achieve tumour necrosis in the liver cancer patient.
CE mark approval has been granted to Biotronik for smaller diameters of the Passeo-18 Lux drug-coated balloon (DCB). The new sizes‰ÛÓ2mm and 2.5mm‰ÛÓare designed to facilitate DCB treatment of below-the-knee arteries.
In November, following the US FDA approval of Cook Medical‰Ûªs Zenith Alpha Thoracic endovascular graft, the first patient was treated with the device in the USA.
Contego Medical presented positive post-market registry data for the Paladin carotid post-dilation balloon with Integrated Embolic Protection Technology at the Leipzig Interventional Course (LINC) 2016, in Leipzig, Germany.
Vascular Solutions has announced the US launch of its enhanced line of VSI Radial introducer sheaths for use in the introduction of guidewires and catheters into veins and arteries.
A new analysis of the MORE data on 606 mCRC patients treated with SIR-Spheres’ Y-90 resin microspheres at 11 US medical centres confirms that patient age is not a barrier to appropriate treatment.
The review, published in the January 2016 issue of the European Journal of Vascular and Endovascular Surgery (EJVES), further concludes that stroke/death rates after carotid stenting often exceed accepted American Heart Association (AHA) thresholds.
Early research on a simple method to produce radiopaque drug-eluting microspheres that can be incorporated into the current clinical transcatheter arterial chemoembolization workflow has also been reported.
Penumbra‰Ûªs POD (Penumbra Occlusion Device) packing coil for the embolization of peripheral vessels and aneurysms adds to its growing peripheral vascular business, which includes the Indigo mechanical thrombectomy system, POD and Ruby embolization coil.
Forge Medical has announced receiving 510(k) clearance from the US FDA for expanded indications of the device to include pedal and tibial haemostasis. The VasoStat was previously cleared for radial artery and dialysis access haemostasis.
NuCryo Vascular has announced receiving 510(k) clearance on the next generation reusable Cryoplasty inflation device. The company has also announced that it will be selling the current and next generation model via a direct sales team.
Darren Klass, Vancouver, Canada, is scheduled to lead a live webinar titled ‰ÛÏWhy radial for interventional radiologists‰Û on 11 January 2016 at 1300hrs Eastern Standard Time.
Patients who feel scared, distressed or hostile before undergoing an interventional radiology procedure may experience a poor outcome, according to research presented at the Radiological Society of North American Annual Meeting (RSNA) in Chicago in early December.
As of mid-December 2015, researchers have activated the first 10 medical sites and enrolled the first nine patients in a large US study that will determine the safety and effectiveness of inferior vena cava filters.
BTG has announced that it has received 510k clearance from the US Food and Drug Administration for LC Bead Lumi, the first commercially available radiopaque embolic bead, for the embolization of hypervascular tumours and arteriovenous malformations.
BTG has announced the successful outcome of the RENEW study, the pivotal US randomised controlled clinical trial comparing the safety and efficacy of the PneumRx endobronchial coil implant with a medical therapy control group in patients with homogeneous and/or heterogeneous severe emphysema. All primary and secondary endpoints of the study were met.
Hansen has announced that it has accelerated the development of the latest addition to the Magellan Robotic System portfolio, the Magellan 3F robotic microcatheter. The development of this important product line expansion has surpassed key milestones and is moving toward the final stages of the development process.
Researchers have developed software for the Microsoft Kinect gaming console that measures body part thickness and checks for motion, positioning and beam adjustment immediately before X-ray imaging, according to a feasibility study presented at the annual meeting of the Radiological Society of North America (RSNA).
People with diabetes may be harbouring advanced vascular disease that could increase their risk of stroke, according to new research being presented next week at the annual meeting of the Radiological Society of North America (RSNA). The findings suggest that arterial imaging with 3D MRI could be useful in helping to determine stroke risk among diabetics.
An interventional radiology technique shows promise for helping morbidly obese patients lose weight, according to the preliminary results of a study presented on 1 December 2015 at the annual meeting of the Radiological Society of North America (RSNA).
The emborrhoid technique used was modelled on the elective transanal Doppler-guided hemorrhoidal artery ligation which had been shown to be effective in haemorrhoidal disease.
While presenting on the trials and updates in deep vein thrombosis, Stephen Kee told delegates at CIRSE 2015 that there was ‰ÛÏan information overload‰Û when Pubmed was searched for ‰ÛÏdeep vein thrombosis‰Û.
Paulo Vilares Morgado, Interventional Radiology Unit, University Hospital S JoÌ£o, Porto, Portugal, presented the results of the AGIR (Angio-Seal in Interventional Radiology) trial at CIRSE 2015.
The study confirms previous findings of single-centre studies that the procedure is associated with a high technical success rate when performed by experienced operators.
The development of an irradiating stent combines the rapid, effective relief of dysphagia through endoluminal stent placement with the longer-term benefits of irradiation/brachytherapy.
Miles Conrad, University of California San Francisco (UCSF), Interventional Radiology section and co-director of the UCSF HHT Centre of Excellence, spoke to Interventional News about a new device being investigated to embolize pulmonary arteriovenous malformations (PAVMs).
Venous interventions, particularly stenting, thrombolysis and thrombectomy are achieving ever-greater significance in the interventional world, Gerard O‰ÛªSullivan, Department of Radiology, University Hospital Galway, Ireland, told Interventional News.
The British Society of Interventional Radiology (BSIR) took its campaign to improve the numbers of interventional radiologists in the NHS to Westminster, UK, in November, highlighting that this was a critical issue that needed significant Government focus.
In the future there will be more TEVAR procedures performed as use of the procedure continues to rise and as it becomes available in smaller centres. The evolution of stent graft design is likely to reduce complications, writes Santi Trimarchi, San Donato Milanese, Italy.
Pulmonary embolism in children is a potentially lethal condition and yet is a vastly understudied arena. Autopsy studies show a higher prevalence of pulmonary embolism compared to medical database registries, suggesting that this condition is often clinically under-recognised.
There are many gains to be had by instituting a drain labelling system within any hospital. It is surprising that this simple and useful practice has not been naturally adopted with the frequency of errors in patient care related to drains alone. In fact, there may be room for industry involvement, writes Theresa Caridi, Georgetown, USA.
Radial access has quickly become my default arterial access after receiving patient feedback. In the last three years, I have adopted it as the default access in most transarterial procedures, writes Marcelo Guimaraes, Charleston, USA.
The Ghana Society of Interventional Radiology (GSIR) was launched on 18 November in Accra. Its aims are to encourage and advance the science and art of interventional radiology in Ghana, writes Benjamin Dabo Sarkodie, founder and president of the society.
Two papers presented at the British Society of Interventional Radiology annual meeting (BSIR, 4‰ÛÒ6 November, Glasgow, UK) highlighted that prostate artery embolization is a technically demanding procedure that is associated with prolonged radiation exposure to the patient and operator.
Interventional News spoke to Kush Desai, Robert Ryu, and Robert Lewandowskion the key findings from their recent paper, and about how to deal with ‰ÛÏthe greatest challenge‰Û of retrieving embedded filters‰ÛÓthe fibrin cap.
As interventional oncologists embrace their growing clinical role and claim their place on multidisciplinary oncological teams, focal therapy is becoming an important part of their practice, according to Afshin Gangi, Strasbourg, France.
The transaction, consisting of an upfront payment of US$70 million and additional payments contingent on regulatory and sales milestones, will expand Boston Scientific‰Ûªs interventional oncology portfolio with drug-eluting microspheres and spherical embolics.
Toshiba announces the launch of the largest and most advanced commercially available mobile CT scanner in the UK. The new mobile imaging innovation already serves 12 CT imaging centres in the UK, travelling 3,500 miles per week from site-to-site.
Hansen has announced the completion of the world’s first clinical procedure using the Magellan Robotic Microcatheter Driver as part of the clinical study, "Embolization procedures in peripheral vasculature‰Û.
Based on the success of its V-Probe variable ice cryoprobe which is used for prostate cryoablation procedures, Endocare has introduced a right angle version of the product. This modification allows the cryoprobe to be used in CT scanners and other limited access areas.
Endologix and TriVascular announced on 26 October that they have entered into a definitive merger agreement under which Endologix and TriVascular will combine in a stock and cash transaction. The transaction is valued at US$9.10 per TriVascular share, or a total of approximately US$211 million, based on Endologix‰Ûªs closing stock price of US$13.81 per share on 23 October 2015.
Jafar Golzarian, a professor of interventional radiology, University of Minnesota, Minneapolis, USA, founded EmboMedics in 2012 and serves as its chief medical officer. He tells Interventional News about the factors driving an interest in resorbable embolics.
While emphasising the interesting findings from their laboratory for interventional radiologists, Olivier Jordan and Katrin Fuchs write that laboratory benches not only give birth to inventions with a potential for translation into clinics, but also contribute to unbiased characterisation of products already in clinical use.
The criteria for first-line therapy are an effective treatment that reproducibly delivers the required endpoint within the limits of acceptable toxicity, and crucially better than any of the other therapeutic options, writes Alice Gillams.
Assessment of tumour response with imaging-based tumour-specific response criteria is a crucial step to identify the value of a new therapy and to help clinicians to predict the prognosis of an individual patient, writes Christoph Zech.
Management of blunt splenic trauma has substantially evolved during the past two decades. Hicham T Abada reviews the literature and outlines the limits of splenic embolization.
Multi-organ trauma, respiratory arrest, severe hypotension, and sepsis are management dilemmas that are confronted regularly in the interventional suite. It is imperative that the interventional radiology team be prepared for these challenges, write Deepak Sudheendra and Joshua Adams.
Bob Abraham, ABK Biomedical, Halifax, Canada, presented computed tomography and magnetic resonance imaging characteristics of novel radiopaque yttrium-strontium-gallium‰ÛÒsilicate oxide glass microspheres at CIRSE.
Merit has announced that it has signed an exclusive worldwide distribution agreement (excluding Japan) with Sumitomo Bakelite to distribute a steerable microcatheter under the proposed trademark of Swiftninja.
It is safe and effective to place biodegradable biliary stents to treat benign biliary strictures. This treatment compares favourably with standard techniques in terms of patients‰Ûª quality of life and avoids the need for repeated invasive procedures, found a study recently presented at the CIRSE conference in Lisbon, Portugal.
Riccardo Lencioni joined Sylvester Comprehensive Cancer Center, Miami, USA, as director of Interventional Oncology Research from the University of Pisa in Italy, where he was a professor at the School of Medicine. Lencioni is an accomplished interventional oncologist, particularly well-known for his influential work on liver cancer.
BTG and Mirada, a medical imaging software company, have announced an important collaboration to develop dosimetry software solutions to optimise radioembolization therapy with TheraSphere.
Jim Reekers, Amsterdam, The Netherlands, delivering the Josef Roesch honorary lecture at CIRSE 2015, urged delegates to look at new definitions for critical limb ischaemia and pointed to the potential of perfusion angiography in predicting the outcome of endovascular intervention. ‰ÛÏLook past the re-opening of vessels alone,‰Û he said.
The five-year outcome data after catheter-directed thrombolysis for upper femoral and/or iliac vein thrombosis, as determined from the randomised, controlled trial, the CaVenT study, were presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) meeting (26‰ÛÒ30 September, Lisbon, Portugal).
Gilles Soulez, MontrÌ©al, Canada, delivered the Andreas Gruentzig lecture at the Cardiovascular and Interventional Radiological Society of Europe‰Ûªs annual meeting (26‰ÛÒ30 September, Lisbon, Portugal). ‰ÛÏWe need to change the way we look at abdominal aortic aneurysms,‰Û he urged.
Galil Medical has announced the launch of its latest product offerings, the Icepearl 2.1 CX and Iceforce 2.1 CX cryoablation needles.
Terumo and Quirem Medical, a commercial stage Dutch medical technology company that focuses on radioembolization, have announced that Terumo has made an equity investment in Quirem Medical.
The company also announced compelling health economic data for TheraSphere at the meeting.
On the back of these results, Stephan MÌ_ller-HÌ_lsbeck announced the commencement of an international multicentre randomised controlled trial that will compare the Eluvia drug-eluting vascular stent system (Boston Scientific) with Zilver PTX, the drug-eluting stent system from Cook Medical. The principal investigators will be MÌ_ller-HÌ_lsbeck (Flensburg, Germany) and William Gray (New York, USA).
The 2015 annual meeting of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) in September in Lisbon, Portugal, marks 30 years since a key meeting in Austria in 1985, in which a merger of two societies led to the birth of CIRSE.
In order to avoid major complications with prostate artery embolization, it is vital to look for collaterals to arteries of the surrounding organs to the prostate, writes JoÌ£o Pisco.
A video featuring renowned American cardiovascular surgeon Edward Diethrich draws attention to the dangers of working with radiation, as it follows his journey in which he discovers that he has a brain tumour.
A new European‰Ûwide observational study to prospectively gather data on patients treated with irinotecan‰Ûloaded microspheres has been launched by the Cardiovascular and Interventional Radiological Society of Europe (CIRSE). The CIRSE Registry for LifePearl microspheres (CIREL) will begin early in 2016.
‰ÛÏThere are strong, visible, women thought leaders in interventional radiology, but a closer look at the numbers is revealing. There are too few women in interventional radiology,‰Û Meridith Englander, Vascular and Interventional Radiology, Albany Medical Center, New York, USA, tells Interventional News.
Results from a retrospective study show that while both glass- and resin-based Y-90 microspheres have demonstrated efficacy as treatment options for unresectable primary hepatocellular carcinoma and hepatic metastatic disease, there is a difference seen in survival between patients treated with the different radioembolics.
Research published in the Journal of the American College of Radiology in June suggests that hospital costs to place a chest port were significantly lower in the interventional radiology suite than in the operating room. Patients who were treated by radiology and surgery did not show a significantly different rate of complications and/or infections.
Y-strut is designed to be implanted using a minimally invasive procedure by orthopaedic surgeons or interventional radiologists.
The infusion technology‰Ûªs unique expandable tip increases drug delivery into the tumour while protecting healthy tissue.
Seven (47%) of the limbs were treated for critical limb ischaemia and eight (53%) for severe claudication.
The Society of Interventional Radiology (SIR) is accepting scientific abstracts covering all areas of vascular and nonvascular interventional radiology for its 41st Annual Scientific Meeting, which will be held 2‰ÛÒ7 April, 2016, in Vancouver, British Columbia, Canada. Online scientific abstract submission is open until 6 October.
The trial‰Ûªs results were published in JACC: Cardiovascular Interventions and show no intracranial haemorrhage and no death among massive pulmonary embolism patients.
GE Healthcare‰Ûªs low dose computed tomography lung cancer screening option is the first to be cleared by the US FDA. Early detection with low dose CT can improve prognosis and treatment and reduce mortality rates for patients with a high risk of lung cancer.
Ricky Sharma, professor and honorary consultant of Clinical Oncology at the University of Oxford and Oxford University Hospitals Trust tells Interventional News: ‰ÛÏWe need to know more about patient selection for radioembolization.
Hansen has announced the completion of the 30th Robotic Prostatic Artery Embolization procedure for the treatment of benign prostatic hyperplasia at Inova Alexandria Hospital in Alexandria, Virginia.
Two recently published papers in the Journal of Vascular and Interventional Radiology (JVIR) reveal that patient materials in interventional radiology available online are way above the understanding of most patients.
InspireMD has announced that it has entered into a partnership with Penumbra to distribute its carotid CGuard EPS through their direct commercialisation team.
The Sonata system from Gynesonics provides a uterus preserving, incision-free treatment option to women suffering from symptomatic uterine fibroids, including those associated with heavy menstrual bleeding.
BTG has announced that Health Canada has issued a notice of compliance approving Varithena (polidocanol injectable foam) for the treatment of incompetent great saphenous veins, accessory saphenous veins, and visible varicosities of the great saphenous vein system, above and below the knee.
Merit Medical has announced that it has received 510(k) clearance from the US FDA expanding indication for QuadraSphere microspheres to include the embolization of hepatoma.
The Journal of Endovascular Therapy (JEVT) has announced the publication of the latest update of the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II), an internationally recognised set of guidelines for the management of patients with peripheral arterial disease.
Cook Medical has initiated a lot-specific voluntary recall of 2,239 lots of Beacon Tip Angiographic Catheters. Globally, 95,167 devices are subject to this recall.
Two-month old successfully treated for vein of Galen formation using interventional radiology technique after simulation on 3D printed model.
The US FDA has approved the Reshape Integrated Dual Balloon System (ReShape). The system is a temporary weight-loss system of gastric balloons that are placed in a minimally invasive manner to occupy space in the stomach. They should be removed after six months.
Emba Medical has announced receiving the European CE mark for the Hourglass peripheral embolization plug making the device the first over-the-wire embolic device cleared for EU commercial release.
Guerbet has announced entering into a definitive agreement under which it will acquire Mallinckrodt‰Ûªs contrast media and delivery systems business in its entirety for approximately US$270 million. With this acquisition, Guerbet aims to create a new global leader in medical imaging.
The grant proceeds will be used to continue the development of a novel, over-the-wire, called Blockstent microcatheter embolic device, for the occlusion of peripheral arteries and veins.
Robert Morgan, vascular interventional radiologist, St Georges Hospital, London, UK, tells Interventional News why he uses liquid embolic agents, such as ethylene vinyl oxide copolymer (EVOH-based) liquid agents, of which Onyx (Medtronic) is an example, for endoleak embolization.
Preclinical research published online ahead of print in the Journal of Vascular and Interventional Radiology (JVIR) in July shows that combretastatin A4 is a stronger inhibitor of the smooth muscle cell cycle than sirolimus or paclitaxel. Thus, it may represent an alternative coating for drug-eluting stents and balloons in atherosclerotic luminal stenosis, the investigators write.
In order to evaluate long-term outcomes of the durability of EVAR, researchers examined US Medicare data from 2001‰ÛÒ2008 involving nearly 80,000 patients who had undergone elective repair of AAA. Half of the patients had open procedures, and half had EVAR.
Carestream Health entered the radiography/fluoroscopy market with two systems that deliver high-quality, cost-effective imaging: the Carestream DRX-Excel Plus.
Kem Hawkins, president of Cook Group Incorporated, retired on July 1 after 34 years with the Cook organisation. Hawkins will remain on the board of directors for Cook Group. Pete Yonkman, current president of Cook Medical, has been chosen as Hawkins‰Ûª successor as president of Cook Group.
Hans van Overhagen and Jim A Reekers , the authors, urge that every symptomatic patient with uterine myomas should be offered embolization as alternative treatment to hysterectomy/myomectomy. "UAE should be incorporated in the (national) gynaecological guidelines," they report.
SIR-Spheres Y-90 resin microspheres and chemotherapy extends progression-free survival of metastatic...
Adding SIR-Spheres Y-90 resin microspheres to first-line chemotherapy for patients with unresectable metastatic colorectal cancer in the liver (mCRC) further extends progression-free survival in that organ.
While there is a trend towards using smaller sized particles to obtain better results with embolization, experts at the Global Embolization Symposium and Technologies (GEST EU) agreed that there appeared to be a lower size limit, <100åµm, below which drug-eluting beads did not have an effective embolic effect.
The company will showcase the Magellan 6F robotic catheter being used by interventional radiologists in embolization procedures, and will conduct Magellan Robotic System demonstrations at exhibit booth #5.
Terumo Interventional Systems had introduced the Misago RX self-expanding peripheral stent to the US market at the 2015 Society for Vascular Surgery Annual Meeting (SVS; 17‰ÛÒ20 June, Chicago, USA).
The new version of syngo.via supports the treating physician in making decisions regarding treatment in oncology through a comprehensive portfolio of applications across imaging systems, treatments, and disciplines.
AngioDynamics has announced a worldwide licensing agreement with privately-held EmboMedics of Minneapolis, USA, which develops injectable and resorbable microspheres. Embolization is the fastest growing segment in interventional radiology, and this newly formed strategic relationship will allow AngioDynamics to leverage the talent and knowledge of its sales team to re-enter the approximately US$150 million addressable global embolic market.
Delcath has announced that abstracts summarising the data from two European studies of treatment with the Delcath Hepatic Chemosat Delivery System will be presented at the upcoming Cardiovascular and Interventional Radiological Society of Europe (CIRSE) annual meeting (to be held in Lisbon, Portugal, 26‰ÛÒ30 September).
BTG has announced the treatment of the first patient in Singapore with TheraSphere, a treatment for primary liver cancer and metastatic colorectal cancer, specifically engineered to deliver powerful doses of radiation to the tumour while minimising exposure to normal tissue in a procedure called radioembolization.
Fortrex utilises a high pressure balloon to break up the blockages and open the vessels to help maintain arteriovenous access in the peripheral vascular system.
Having performed over 400 irreversible electroporation treatments at the University of Miami, USA, Govindarajan Narayanan believes that certain niche applications of the technology have demonstrated tremendous value and hold a lot of promise for patients.
The ability to achieve bleeding control in critically ill patients seems to depend chiefly on early intervention and severity of the underlying disease, such as coagulation disorders, writes Romaric Loffroy, Dijon, France.
Percutaneous osteosynthesis consists of inserting screws into bone structures through a skin incision of less than 10mm. It is now performed percutaneously by interventional radiologists due to the development of cannulated screws inserted coaxially over a guide pin, and due to the level of accuracy possible with CT- or flat panel-guidance, writes FrÌ©dÌ©ric Deschamps.
Hydatid disease (cystic Echinococcus) caused by Echinococcus granulosus is an endemic disease and a significant public health problem in many parts of the world.
BEAT Obesity is a physician-sponsored investigational device exemption single-arm prospective clinical trial for five to 15 morbidly obese patients using used (off-label) is 300‰ÛÒ500ë_m Embosphere microspheres (Merit Medical).
A study from Institut BergoniÌ¬ (Bordeaux, France), in collaboration with UniversitÌÊ Campus Bio-Medico di Roma (Rome, Italy), has found that cone-beam CT is faster than CT.
Researchers from Stanford University have created a mobile application to allow rapid identification of all inferior vena cava filter types and related complications.
These findings have particular relevance for the many women undergoing uterine artery embolization who are of child-bearing age, as well as for the interventional radiology staff present in the room during the procedure.
The Aneurysm Coiling Efficiency registry offers an opportunity to study the demographics and long-term outcomes of a cohort of patients with embolization of the peripheral vasculature using Ruby coils (Penumbra).
This clearance is in addition to obtaining the CE mark to market in Europe and AMAR approval to market the device in Israel.
Interventional radiologists and urologists in France are teaming up to set up a multidisciplinary registry to collect data on prostatic artery embolization for the treatment of benign prostatic hyperplasia.
Premedication with an oral antioxidant cocktail before medical imaging exams could significantly reduce DNA injury from the ionising radiation dose, finds new research presented at the Society of Interventional Radiology‰Ûªs annual scientific meeting in Atlanta, USA.
With the hospital‰Ûªs new å£430m Brunel building offering pioneering treatment within state-of-the-art facilities, Siemens technology is increasing the speed of patient assessment and enabling elevated levels of patient throughput.
Philips has announced the launch of Ultrasound on Demand in the UK, an on-demand ultrasound solution which will go live on 1 June 2015.
The World Conference on Interventional Oncology (WCIO) is developing an online interventional oncology curriculum called IO University. Michael Soulen, immediate past chair of the...
The positive 30-day results from 120 patients out of a planned 240 patient cohort at high risk for endarterectomy, who underwent carotid artery stenting using the Wirion embolic protection device (Allium Medical), were published in EuroIntervention and presented at EuroPCR 2015 (19‰ÛÒ22 May, Paris, France).
The SIRFLOX trial results will be presented by Peter Gibbs, co-principal investigator of the SIRFLOX trial, in the oral abstract session on gastrointestinal (colorectal) cancer at the American Society for Clinical Oncology (ASCO) annual meeting in Chicago, USA, on Saturday, 30 May 2015.
Hansen has announced the completion of the world’s first clinical procedure with the Magellan 10F robotic catheter. Interventional radiologist Gerard Goh performed the procedure at The Alfred Hospital in Melbourne, Australia. He used the 10F catheter during a robot-assisted placement of an inferior vena cava filter.
Surefire Medical has announced that the company‰Ûªs new Precision targeted delivery infusion system, for direct-to-tumour embolization procedures, has received the CE mark from European regulators. Surefire infusion systems are today used primarily in treating inoperable liver cancers, although clinical trials are under way for additional medical conditions.
Quiremspheres, that were developed by the University Medical Center (UMC) Utrecht, The Netherlands, to be used in a new treatment for liver cancer, have received the European CE mark for quality and safety. The treatment is being marketed by Quirem Medical, a spin-off company of the UMC Utrecht.
EndoShape has announced that it has been selected to present at the Cavendish Global Health Impact Forum taking place 10‰ÛÒ14 May in La Jolla, USA.
VesselNavigator has been designed for use in conjunction with Philips‰Ûª interventional X-ray systems to guide catheters during treatment of vascular disease.
Yasuaki Arai, director of the National Cancer Center Hospital, Tokyo, Japan, and current president of the Japanese Society of Interventional Radiology (JSIR), delivered the Honorary Lecture at the European Conference of Interventional Oncology (ECIO) in Nice, France, yesterday. He spoke on the topic ‰ÛÏBeyond the evidence‰ÛÓthe true goal of interventional oncology‰Û and received a standing ovation for his presentation.
Teleflex will showcase a wide array of products for minimally invasive interventional applications at the 6th European Conference of Interventional Oncology (ECIO) in Nice, France, from 22‰ÛÒ25 April 2015.
A new study reveals that a new angiographic imaging platform (AlluraClarity, Philips Healthcare) maintains similar procedure time as a current C-arm imaging platform (Allura, Philips), yet with substantially reduced radiation exposure for uterine artery embolization procedures.
Portal vein embolization using Histoacryl (B.Braun), a tissue seal adhesive, from an ipsilateral approach is a safe and effective technique to prepare for liver surgery, new research reveals.
Terumo has announced that on 16 March 2015 it received CE mark for LifePearl, a new drug-eluting microsphere for chemoembolization and HydroPearl, a new microsphere for more predictable bland embolization.
BTG began selling its drug-eluting bead and embolization products, DC Bead and Bead Block, directly to customers in 11 European countries on 1 April 2015.
The programme will begin with two studies designed to address the confounding factors from the SYMPLICITY HTN-3 trial, including medication, patient population and procedural variability, to ensure the clinical potential of the therapy.
David Sacks analyses the results of the MR CLEAN study and finds that with three other randomised intra-arterial stroke trials presenting positive results for the intra-arterial arm, the treatment landscape is poised for change.
It is natural to focus on the positive aspects of transpedal access and its value in infrainguinal revascularisation. However, we should not shy away from considering the limitations of this approach in order to obtain the best results for our patients, writes Jihad A Mustapha.
During the periprocedural phase, correct technique, operator experience, accurate lesion and patient selection and the adequate use of an embolic protection device are essential factors to improve results.
Despite the fact that interventional radiology procedures are minimally invasive and offer a quicker recovery time, in the majority of interventional radiology departments, patients still need to occupy a hospital bed even for elective procedures.
Alessandro Napoli writes that therapeutic ultrasound still has some technological hurdles that need to be overcome, despite his success with the treatment over the past five years.
An overview of three treatments: ablation, chemoembolization and selective interval radiation therapy, should clarify the challenges of determining tumour response in interventional oncology, write Maxime Ronot and ValÌ©rie Vilgrain.
Forge Medical, manufacturer of the VasoStat haemostasis device that is used for radial artery and dialysis access haemostasis, announced that the company has entered into a national commercialisation agreement for the device with National Medical Sales.
A study from France presented at the European Congress of Radiology (ECR, 4‰ÛÒ8 March, Vienna, Austria) has found that percutaneous thermal ablation is safe and effective for local control of metastatic breast cancer.
A single-centre review of the safety and feasibility of using the transradial approach for peripheral and visceral interventions after the first 1,000 procedures finds that this access has extremely low complication rates.
Preliminary data from a multicentre study carried out in Europe and Argentina show that percutaneous bioresorbable biliary stent placement is feasible in a large majority of cases, and that it represents a safe and effective novel treatment of benign biliary strictures.
Can the industry be persuaded to provide previous-generation products that would otherwise be incinerated, to people in the developing world who cannot otherwise afford them? Mathew Cherian, asks.
In the first-line treatment of non-resectable metastatic colorectal cancer, the preliminary analysis of the SIRFLOX study results does not show a statistically significant improvement in overall progression-free survival ie, at any site. However, the study does show a statistically significant improvement in progression-free survival in the liver.
The system is now available in the UK, Ireland, Germany, Spain and Italy, and provides deployment for what Cook Medical says is the world‰Ûªs first and only approved drug-eluting stent for the superficial femoral artery.
Bracco Imaging, through its business unit Bracco Injeneering SA, has announced the availability of its EmpowerCTA+, an advanced engineering contrast injection system that puts the radiologic technologist in control in the computed tomography suite.
Early data from a multicentre, single-arm study that set out to evaluate the safety and effectiveness of a novel approach to inferior vena cava filtration using the VenaTech convertible filter (B Braun Interventional Systems) suggest that the use of this device yields favourable results.
The study of yttrium-90 resin microspheres versus sorafenib in advanced hepatocellular carcinoma has enrolled more than 400 patients, with results expected in late 2016.
Interventional radiologists use 3-D printers to develop personalised medical devices that can deliver antibiotics and chemotherapy in targeted manner.
Medikidz has published the ‰ÛÏMedikidz Explain Primary Liver Cancer‰Û comic book to help children understand and cope with the realities of life during what is often a very challenging time.
88% of patients report using less pain-relief medicine after intranasal sphenopalatine ganglion blocks.
According to research presented at the Society of Interventional Radiology‰Ûªs (SIR‰Ûªs) annual scientific meeting, clinicians were able to use prostate artery embolization to improve patient symptoms, regardless of the size of benign prostatic hyperplasia before the treatment, researchers found in a retrospective study.
Research from the Society of Interventional Radiology‰Ûªs annual scientific meeting shows image-guided, ultrasonic technology may hold key to conquering a difficult condition.
Researchers at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust are investigating whether ultrasound therapy can relieve pain in patients whose cancers have spread to the bone.
Penumbra has announced that its newest vascular embolization device, POD, will debut at the Society of Interventional Radiology 2015 annual scientific meeting in Atlanta, USA.
Analysis of a 285-patient subgroup treated with ThermoDox plus radiofrequency ablation shows a statistically significant 59% improvement in overall survival when compared to patients who were treated with optimised radiofrequency ablation alone.
Study launched to evaluate the effectiveness of CorPath robotic assistance in performing balloon angioplasty for symptomatic peripheral arterial disease.
The study includes 65 investigational sites in the USA, Canada, UK, Denmark, Norway, Sweden, and Finland that enrolled a combined 664 subjects.
A study that set out to assess the safety and efficacy of prostate artery embolization in small volume benign prostatic hyperplasia (<50cc) revealed that the procedure appears to offer positive clinical benefits for patients out to six months.
Horst Sievert, CardioVascular Center, Frankfurt, Germany reported ‰ÛÏinteresting, but inconclusive observations‰Û from a small cohort of patients enrolled in the RETREAT (Renal denervation with ultrasound after failed radiofrequency denervation) study.
The system is for use during carotid artery stenting procedures and is the first one designed to access the carotid arteries through an incision in the neck, instead of the groin.
The ROX CONTROL HTN, an international randomised controlled trial, published online ahead of print in The Lancet in late January, has demonstrated that creation of a central arteriovenous anastomosis in patients was associated with significantly reduced blood pressure and hypertensive complications at six months. The study was funded by Rox Medical.
Longer and lower profile options now available in Canada to treat more patient anatomies.
US hospitals this week began using the IN.PACT Admiral drug-coated balloon (Medtronic plc) to treat patients with peripheral arterial disease in the superficial femoral and popliteal arteries.
A new computer programme allows interventionalists to assess blood flow in real-time while they are using flow-diverter devices to treat intracranial aneurysms, suggests a pilot study being presented at the 27th annual International Symposium on Endovascular Therapy (ISET, 31 January‰ÛÒ5 February, Hollywood, USA).
Results from a phase I study using an attenuated strain of Clostridium novyi (C novyi-NT) show that bacterial spores can be delivered using existing imaging technologies and devices to demonstrate clinical evidence of germination and confirms the capability of inducing oncolysis in human neoplastic tissues.
Sirtex has announced the completion of patient enrolment in FOXFIRE and FOXFIRE Global, two large multicentre studies that added liver-directed radiation therapy with SIR-Spheres Y-90 resin microspheres to a current standard of care chemotherapy regimen in the first-line treatment of more than 560 patients recently diagnosed with inoperable metastatic colorectal cancer.
The primary patency at 12 months was 89.5% in the pre-dilation plus drug-coated balloon group and 77.5% in the direct drug-coated balloon group.
InspireMD says that the RX delivery system, designed for use with the CGuard MicroNet, will enable clinicians to place the CGuard technology using an easy-to-use, and familiar, delivery system.
Hansen has announced the completion of the first clinical procedure with the Magellan robotic system in Australia.
Data presented at the Leipzig Interventional Course 2015 (LINC, 27‰ÛÒ30 January, Leipzig, Germany) demonstrate significant improvement in dissection repair with the Tack Endovascular System (Intact Vascular).
Clinical work and data will be presented on Humacyte‰Ûªs novel bioengineered blood vessel at the 27th International Symposium on Endovascular Therapy (ISET, 31 January‰ÛÒ4 February, Hollywood, USA).
The Society of Interventional Radiology Foundation has released a statement announcing that the NIH-sponsored ATTRACT (Acute venous thrombosis: thrombus removal with adjunctive catheter-directed thrombolysis study) has completed accrual of its originally planned cohort of 692 patients.
Alan Lumsden, vascular surgeon and director of the Methodist DeBakey Heart & Vascular Center, performed the procedure at Houston Methodist Hospital in Houston, Texas using the Magellan robotic system (Hansen Medical) to remove a filter manufactured by Cook Medical.
Bariatric embolization is the first catheter-based procedure that attempts to directly address obesity. The minimally invasive technique is expected to decrease the hormone ghrelin, responsible for appetite, resulting in weight loss.
The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) has launched a new observational study that will gather data on patients with primary and secondary liver tumours treated with SIR‰ÛSpheres microspheres at specialist hospitals across Europe.
A research group from Italy has recently detailed their early experience using one-shot scleroembolization to treat varicose veins of the lower extremities.
Peer-reviewed published research reconfirms clinical benefits and cost-effectiveness of chlorhexidine/silver sulfadiazine-impregnated central venous catheter.
Lombard has announced the formal opening of the company‰Ûªs new cleanroom, which will enhance the global operating footprint and production capabilities of their lead product, Aorfix, to meet increased worldwide customer demand.
Veniti has announced the first use of the Vici venous stent system in Germany. The system is used to treat venous outflow obstruction in the lower extremities. The procedures were performed by Michael Lichtenberg, head of Interventional Angiology, Klinikum Arnsberg, Arnsberg, Germany.
Jafar Golzarian, SIR 2015‰Ûªs programme chair, discusses some of the most exciting sessions from the Society of Interventional Radiology‰Ûªs (SIR‰Ûªs) upcoming Annual Scientific Meeting (28 February‰ÛÒ5 March 2015, Atlanta, USA) for Interventional News.
The results of a web-based survey designed to shed light on the practice of transarterial chemoembolization (TACE) in the UK have shown that there is a wide variation in practice with some centres using conventional TACE (with lipiodol and doxorubicin) and others using, newer drug-eluting beads.
CeloNova BioSciences has announced that it has received an expanded indication (CE mark) in Europe for its Embozene embolic microspheres to include the treatment of benign prostatic hyperplasia.
The Society of Interventional Radiology (SIR) has launched a new brand, reinforcing interventional radiology‰Ûªs commitment to developing breakthrough treatments, enhancing medical practice and improving standard of patient care through image-guided therapies.
Lithoplasty is a novel balloon-based technology that uses integrated lithotripsy, a pulsatile mechanical energy commonly used to break up kidney stones, to disrupt both superficial and deep calcium and normalise vessel wall compliance prior to low-pressure balloon dilatation.
Straub Medical has announced that the Chinese FDA has recently approved the Straub Endovascular System with its Rotarex S and Aspirex S rotational catheter families.
Kypho-IORT (Combining intraoperative radiotherapy with kyphoplasty for treatment of spinal metastases) will test a new combination treatment that delivers radiation directly to the tumour and increases support of the spine.
Johns Hopkins researchers have developed a sugar-based molecular microcapsule that eliminates the toxicity of an anticancer agent developed a decade ago at Johns Hopkins, called 3-bromopyruvate, or 3BrPA, in studies of mice with implants of human pancreatic cancer tissue.
The results of a new study show that prophylactic placement of internal iliac balloons prior to elective Caesarean section is technically feasible, well-tolerated and leads to satisfactory maternal and foetal outcomes with minimal complications.
The Gore Viabahn Endoprosthesis has received CE mark approval to improve blood flow in symptomatic obstruction of peripheral veins, excluding the venae cavae and pulmonary veins.
Catheter robotics is in the early stages of evolution. A new 6F catheter, designed to permit diagnostic angiography, delivery of embolic agents and access to more distal vasculature such as the below-the-knee vessels, has recently become commercially available.
CO2 angiography can decrease both morbidity and mortality for patients, in certain clinical scenarios. For those driven by economics, the cost of 100cc of CO2 is approximately three cents. Its use is limited only by one‰Ûªs imagination. So why is it not more widely used?
Stentoplasty, or vertebral body stenting, represents the next step in the evolution of cement spinal augmentation where a stent is placed within the vertebral body followed by infusion of cement.
Silk Road Medical‰Ûªs 30-day outcomes from the ROADSTER IDE study were presented at the Late Breaking Clinical Trials Session at the 2014 Vascular InterVentional Advances Meeting in Las Vegas, with additional data presented at the VEITHsymposium in New York.
Lombard Medical has released efficacy and safety data from the two-year follow up of the US PYTHAGORAS pre-marketing approval trial of Aorfix.
Lindsay Machan reviews the use of a dynamic collimation system to reduce radiation exposure to the operator, staff and patient during fluoroscopy and cine.
Viral oncolysis is an exciting area of research with applications to tumours throughout the body. Understanding the background and development of viral oncolytic therapy is important for future applications.
With the US shift in practice model and the advent of the ‰ÛÏInformation Age‰Û, interventional oncologists need to communicate with their patients more frequently and at more depth.
Hugo Rio Tinto from Lisbon, Portugal, has been busy flying all over Europe, but also further afield to Russia, China and India to help train those interested in prostatic artery embolization.
Hansen Medical has announced the completion of the first robotic prostatic artery embolisation (PAE) in the USA performed using the Magellan robotic system.
The first large-scale, multispecialty prospective clinical research trial to evaluate the use of inferior vena cava (IVC) filters and related follow-up treatment in the USA is set to enrol the first patient in spring 2015 with participation from seven filter manufacturers.
Embolization therapy combined with infusion of antineoplastic agents offers considerable improvement of symptoms for patients, with far fewer complications than systemic chemotherapy, writes Shinichi Hori, Osaka, Japan.
The six-month results of the VeClose pivotal study demonstrated the safety and effectiveness of the VenaSeal closure system in patients with chronic venous insufficiency having symptomatic reflux in the great saphenous vein.
CeloNova BioSciences has announced that the US FDA has granted approval to start an investigational device exemption (IDE) clinical trial for its Oncozene embolic...
This new data reveals the importance of access to 24/7 interventional radiology and the need to ensure availability of interventional radiologists in emergency care. There is a wide variation in the availability of 24/7 interventional radiology across the UK, which means that patients in some parts of the country do not receive the benefits of minimally invasive modern medicine in the emergency setting.
Lazarus Effect has announced that the Lazarus Cover accessory device has received CE mark. The Lazarus Cover is a nitinol-mesh cover that surrounds a retriever device and captured material during removal from a blood vessel.
Five-year results from the largest and longest-running clinical trial of a drug-eluting stent for treating peripheral arterial disease confirmed long-term patency for patients treated with Zilver PTX (Cook).
Medtronic‰Ûªs IN.PACT Admiral drug-coated balloon, used for the treatment of peripheral artery disease in leg arteries above the knee, provided a consistently favourable treatment effect in patients with diabetes in a landmark study of the investigational medical device, which is under review by the US Food and Drug Administration (FDA) for approval.
Terumo Europe has announced the creation of an Interventional Oncology division that will be active as of 1 April 2015. The specialisation of the...
Hansen, has announced that the Magellan 6F robotic catheter has received CE marking for use in the peripheral vasculature, allowing the company to market the catheter in Europe and other countries.
Delays in revascularisation of diabetic foot in the UK directly relate to legs being lost to amputation. Early referral to interventionists is of critical importance and interventional radiologists must prioritise the revascularisation of diabetic foot patients to help save legs, a UK multidisciplinary panel recommended.
The upcoming British Society of Interventional Radiology (BSIR) Annual Meeting (12‰ÛÒ 14 November 2014 BT Convention Centre, Liverpool, UK) will present a snapshot audit titled ‰ÛÏ7 days, 7 sites, 24/7 Interventional Radiology‰Û with data recorded over the course of a week from seven UK hospital sites providing acute interventional radiology care.
A study that examined the incidence of cerebral microembolization and silent cerebral infarction after thoracic endovascular aneurysm repair (TEVAR) concluded that two-thirds of patients undergoing MRI had evidence of silent cerebral infarctionå_‰ÛÓa previously unrecognised burden.
Spectranetics and Covidien have announced a definitive agreement under which Spectranetics will acquire Covidien‰Ûªs Stellarex drug coated angioplasty balloon platform for US$30 million.
There is a compelling case for the medical community, including the device industry, to develop specific devices that are appropriate for paediatric patients, say opinion leaders in the field.
The 12-month results of the Italian multicentre study, presented at CIRSE 2014, demonstrated that new microwave technology can achieve a substantial rate of complete necrosis of liver metastases, even in a short-term treatment with few major complications.
There is a compelling case for the medical community, including the device industry, to develop specific devices that are appropriate for paediatric patients, say opinion leaders in the field.
Suresh Vedantham spoke to Interventional News on the latest from the paper ‰ÛÏQuality improvement guidelines for the treatment of lower-extremity deep vein thrombosis with use of endovascular thrombus removal‰Û.
The International Carotid Stenting Study (ICSS) randomised trial has reported the long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis in The Lancet online ahead of print on 14 October.
Siemens Healthcare introduced the Symbia Evo Excel SPECT system at the 27th Congress of the European Association of Nuclear Medicine. The system is a new version of the successful Symbia E.
Hansen has announced the completion of the first robot-assisted uterine fibroid embolization in the USA. Sandeep Rao, interventional radiologist, performed the procedure at Sierra Medical Center in El Paso, Texas, using the Magellan Robotic System.
The company has announced that commercial cases were performed at The University Hospital, Leuven, Belgium, where Geert Maleux successfully treated two patients with the EOS device.
Lombard has announced the successful completion of the first two EVAR cases performed in New Zealand using Aorfix, an endovascular stent graft for abdominal aortic aneurysm repair.
The ALN inferior vena cava filter has been available in the European market for over a decade. Following US FDA approval a few centres in the USA have gained extensive experience with this filter. A retrospective study reporting intermediate-term experience from the University of Texas Medical was presented at CIRSE 2014.
BTG has announced that it will begin selling its drug-eluting bead and embolization products, DC Bead and Bead Block, directly to physicians in 11 European countries from 1 April 2015. These products, developed and manufactured by BTG, are currently sold in Europe by the Terumo Corporation under a contract that expires on 31 March 2015.
A retrospective analysis from Wales, UK, reported at CIRSE 2014, finds that although there are no randomised controlled trials comparing open and endovascular repair of mycotic aortic aneurysms in the thorax and abdomen, endovascular aneurysm repair (EVAR) in these patients is favourable.
One-year results from a randomised study comparing fibred platinum coils to vascular plugs for the embolization of pelvic varices in order to treat pelvic congestion syndrome have shown that plugs are as good as coils with regard to safety and efficacy. In addition, plugs also significantly reduce procedure and fluoroscopy time, and radiation dose, the study finds.
Six-month results from the randomised clinical trial, BIOLUX P-II, that compared the Passeo-18 Lux paclitaxel-releasing balloon (Biotronik) vs. plain balloon angioplasty with the uncoated Passeo-18 balloon in the treatment of infrapopliteal artery lesions, have shown that the drug-eluting balloon results in significant clinical improvement of Rutherford 5 patients.
ReFlow Medical has announced the initial clinical use of their Wingman35 crossing catheter and speX shapeable support catheter by Andrej Schmidt, Park Hospital Leipzig, Germany. The devices were recently granted CE mark approval for use in the peripheral vasculature.
Newly published European Society for Medical Oncology (ESMO) clinical guidelines for the treatment of metastatic colorectal cancer endorse radioembolisation, specifically with yttrium-90 (Y90) resin...
The audience in the CIRSE 2014 ‰ÛÏControversies in superficial femoral artery treatment‰Û session failed to endorse two motions pertaining to drug-elution in this anatomical segment in the annual meeting (12‰ÛÒ17 September, Glasgow, UK).
Although current evidence in favour of catheter-directed thrombolysis for deep venous thrombosis may not be robust enough to allow for a shift in clinical practice, that may soon change with strict adherence to thrombolysis exclusion criteria, meticulous interventional techniques, and close treatment monitoring to minimise the risk of bleeding complications with catheter-directed thrombolysis, write Stephen T Kee and Adam Plotnik.
William T Kuo presented the initial results of the multicenter PERFECT registry at CIRSE 2014 (the annual scientific meeting of the Cardiovascular and Interventional Radiological Society of Europe, 12‰ÛÒ17 September, Glasgow, UK).
A special session at the CIRSE 2014 conference in Glasgow, UK, took a close look at the field of renal denervation as it stands today and concluded that there is still plenty of life and promise in the field. This is not the end of renal denervation but the beginning of proper evaluation, experts said.
The Interventional News team is in Glasgow, UK, for CIRSE 2014 with a brand-new print edition. If you are at the congress, do pick up your copy from booth 12.
Sirtex has announced the expansion of its business in Latin America. Sirtex’s SIR-Spheres microspheres are now available to treat inoperable liver tumours in Brazil. The...
Celsion Corporation has announced that the first patient has been enrolled in its pivotal phase III OPTIMA study of ThermoDox in combination with optimised...
CeloNova has announced US FDA 510(k) clearance expanding the indication for their Oncozene and Embozene microsphere products to now include the embolization of hepatocellular carcinoma.
Tim A Fischell writes that chemical renal denervation using ethanol may have numerous advantages over energy-based ‰ÛÏburning‰Û technologies.
Randomised, sham-controlled clinical trial of non-invasive, ultrasound therapy for resistant hypertension...
Kona Medical has announced the initiation of the WAVE IV, randomised, sham-controlled, double-blinded, clinical trial of its Surround Sound Hypertension Therapy System. The trial will treat 132 patients at sites in Europe, New Zealand, Australia, and South America.
BTG and its partner SciClone Pharmaceuticals have announced that the China Food and Drug Administration has approved the registration of DC Bead for the...
A study group at the Comprehensive Cancer Centre of Medical University of Vienna and AKH Vienna under the guidance of Maria Sibilia from the...
Results from this analysis demonstrated that during the 12-month extended treatment of venous thromboembolism, Eliquis significantly reduced the risk of hospitalisation versus placebo.
Covidien has announced that it has acquired Sapheon, a privately-held developer of venous disease treatments. Financial terms of the transaction were not disclosed.
The Adelante Magnum is a high performance haemostatic valve introducer for large size vascular access, specifically designed and optimised for the introduction and placement of endovascular catheters, aortic valves, and stent graft systems.
The findings from a report commissioned by the Canadian Interventional Radiology Association (CIRA) and carried out by the Millennium Research Group (MRG) indicate that Canada lags behind other industrialised countries in the G7 such as Europe, USA and Japan in the adoption of interventional radiology treatment.
The Society of Interventional Radiology (SIR) has issued a global call for scientific abstracts covering all areas of vascular and nonvascular interventional radiology for its 40th Annual Scientific Meeting, which will be held 28 February‰ÛÒ5 March at the Georgia World Congress Center in Atlanta, USA.
The case was performed by one of the study‰Ûªs principal investigators, Peng Liu, professor at the China-Japan Friendship Hospital in Beijing, China.
The case was performed by one of the study‰Ûªs principal investigators, Peng Liu, professor at the China-Japan Friendship Hospital in Beijing, China.
By Aravind Arepally Despite the rapid growth of imaging and treatment options in interventional oncology, one area that has been poorly understood and overlooked by...
Women could be at higher risk for adverse outcomes than men, but overall they have similar procedural success compared with men despite higher complications rates, data from a study published in Journal of the American College of Cardiology in June suggests.
New data presented at the Society of NeuroInterventional Surgery (SNIS) 11th Annual Meeting in (28 ‰ÛÒ31, Colorado Springs, USA) helps prove that written care protocols can significantly improve the overall emergency care pathway for stroke.
Vascular Solutions has announced the US market launch of its Gel-Bead embolization spheres for the treatment of hypervascular tumours.Gel-Bead embolization spheres are precisely sized,...
ArtVentive has announced positive clinical results in conjunction with expanded enrolment in the ArtVentive Endoluminal Occlusion System (EOS device) OCCLUDE I post-market surveillance study.
Hansen Medical and Adachi have announced a distribution agreement for Magellan and Sensei robotic systems in Japan. As part of the distribution agreement, Adachi is responsible for obtaining Japanese Marketing approval from the Pharmaceuticals and Medical Devices Agency for the Magellan and Sensei systems.
Teleflex has announced it has received FDA 510(k) clearance to market its Arrow-Clark Vectorflow chronic haemodialysis catheter. The catheter features a symmetrical tip design that allows ease of placement.
The Spectranetics Corporation has announced receiving US FDA 510(k) clearance of their peripheral atherectomy products, Turbo-Tandem and Turbo Elite, for the treatment of in-stent restenosis.
The Canadian Network for Environmental Scanning in Health (CNESH) has selected Cook Medical‰Ûªs Zilver PTX drug-eluting peripheral stent as a top 10 game-changing health technology for 2014.
Cyanoacrylate adhesive embolization using the VenaSeal Sapheon Closure System (Venaseal) of the incompetent great saphenous veins offers several advantages over endothermal ablation including not requiring tumescent anasthaesia and use of compression stockings after the intervention.
DFINE has announced the publication of a multicentre study in the July/August issue of Pain Physician Journal, the official peer-reviewed publication of the American...
A new series of expert consensus recommendations developed by the Society for Cardiovascular Angiography and Interventions (SCAI) will help physicians determine the best course of action for patients whose blockages reduce blood flow to their limbs, putting them at risk for gangrene and amputation.
A small study conducted in Japan, published in CardioVascular and Interventional Radiology in July 2014, demonstrates that transcatheter arterial embolization is feasible and that it rapidly relieves pain associated with knee osteoarthritis and restores knee function.
Overcoming a significant roadblock to predictable ablation of soft tissue, Covidien has unveiled an advanced ablation system that offers physicians predictable results regardless of the...
A study published online ahead of print in July in the Journal of Vascular and Interventional Radiology (JVIR) provides a technical description of robot-assisted uterine artery embolization and investigates the safety and feasibility of using the Magellan system (Hansen Medical) robotic catheter in the uterus.
A study from Denmark finds that the most important factors to predict long-term competent veins after catheter-directed thrombolysis are symptom duration of less than two weeks and use of the pulse spray technique.
EmboCoh is a structured international web-based channel, designed so that physicians can enter their data on embolization procedures. It will enable collaborative registry-style data collection and analysis, particularly of uncommon embolization procedures, which would not be meaningfully possible from single-centre data due to the paucity of cases.
By Steven C Rose The evidence supporting the use of transarterial chemoembolization (TACE) and Yttrium-90 transarterial radioembolization (TARE) to treat primary and secondary liver malignancies...
James F Benenati, medical director, Baptist Cardiac and Vascular Institute‰Ûªs, Peripheral Vascular Laboratory, Miami, USA, delivered the 2014 Charles T Dotter Lecture on 23 March at the opening plenary of SIR‰Ûªs 39th Annual Scientific Meeting in San Diego, USA.
Many studies have demonstrated technical success rates of greater than 95% for gonadal vein embolization and that the procedure has resulted in a significant relief of symptoms in 68‰ÛÒ100% of patients over a range of follow up periods, writes Sandeep Bagla.
The 11th Scientific Meeting of the Chinese Society of Interventional Radiology (2014 CSIR) was held from 11‰ÛÒ15 June 2014 in Changsha, Hunan Province, China. The Chinese Society of Interventional Radiology writes this report for Interventional News.
BSD Medical Corporation reported that Terumo Europe NV (Terumo) has obtained approvals to market and import the MicroThermX Microwave Ablation System in South Africa,...
Gynesonics announces the first successful treatment using a transcervical fibroid ablation technique guided by integrated ultrasound imaging.
The minimally-invasive flow diversion device for unruptured brain aneurysms is designed for more accurate, controlled placement.
The number of European Society of Radiology members has just passed the 60,000 mark, making it by far the largest community of radiologists in the world.
Findings from a review of the United States Food and Drug Administration Manufacturer and User Facility Device Experience (MAUDE) database reveal that complications occur with significantly higher frequency when retrievable inferior vena cava filters are placed than permanent filters.
The UK-ROPE (Registry of prostate embolization) has been set up to collect real world evidence because prostate artery embolization has been used in research trials in SÌ£o Paulo in Brazil, Lisbon in Portugal and Southampton in the UK and a few other centres, but has yet to gain full recognition by regulatory bodies in the UK, writes Nigel Hacking.
The Celerity system has been cleared by the FDA as an adjunct to aid in positioning Peripherally Inserted Central Catheters (PICCs) in adults by providing real time catheter tip location utilising the patient’s cardiac electrical activity.
The acquistion creates a medical technology and services company with a comprehensive product portfolio and broad global reach.
The results from a small, animal study challenge previously unsubstantiated published reports claiming that a five to 10mm “ice ball” margin beyond the tumour...
Lutonix DCB is one step closer to becoming the first US FDA-approved drug-coated balloon for the treatment of patients with femoropopliteal occlusive disease.
Combination treatment involving laser debulking followed by drug-eluting balloon angioplasty is associated with superior outcomes when compared to the use of drug-eluting balloon angioplasty alone in critical limb ischaemia patients with superficial femoral artery stent occlusions.
The 16th annual conference of the Indian Society of Interventional Radiology, ISVIR 2014, was held 3‰ÛÒ6 April in Mumbai, India. The theme of the meeting was flow‰ÛÓof ideas, progress, and of course, as physicians who spend a lot of time opening blocked arteries, of blood to the feet!
The Society of Interventional Radiology Foundation‰ÛÓtogether with the Harvey L Neiman Health Policy Institute‰ÛÓinvites US and Canada-based researchers to apply for an inaugural grant opportunity of up to US$30,000 designed to support research evaluating the cost, cost-effectiveness and quality outcomes of interventional radiology interventions in comparison to other treatments.
Pan Medical UK has received US Food and Drug Administration (FDA) approval for the repair of spinal compression fractures with its Kyphoplasty range of products.
A study from Taiwan shows for the first time that penile artery angioplasty is safe and can achieve clinically significant improvement in erectile function in the majority of patients with erectile dysfunction and isolated penile artery stenosis at six months.
The Advanta V12 stent (MAQUET) is the company‰Ûªs proprietary balloon-expandable covered stent technology. Prof. Richard G McWilliams, Radiology Department, Royal Liverpool University Hospital, Liverpool, UK, spoke about his centre‰Ûªs experience with the Advanta V12.
Hansen Medical has announced the successful completion of the first clinical procedures in the USA using the Magellan 6F robotic catheter. Alan Lumsden, treated two patients with the catheter at Houston Methodist Hospital in Houston, USA.
With more research being carried out into uterine artery embolization, the procedure has been found to be far more widely applicable than previously thought and only a few relative and absolute contraindications to it remain, writes Paul NM Lohle.
New live 3D image guidance tool enhances tumour embolization procedures on Philips’ interventional X-ray systems. Philips innovations detect more than twice as many tumour feeding...
By Nishita Kothary Over the years, we have seen a rapid development of tools, tricks and techniques that enable ablation of tumours located in regions...
Research presented at the Global Embolization Symposium and Technologies US (GEST US meeting, 1‰ÛÒ4 May, San Francisco, USA) meeting suggests that patients undergoing transhepatic interventions should have tract embolization performed to prevent haemorrhagic complications.
A study from Lublin, Poland, that set out to evaluate the results of selective catheterisation of occluded fallopian tubes and its effect on fertility was presented at the Global Embolization Symposium and Technologies US (GEST US, 1‰ÛÒ4 May, San Francisco, USA) meeting.
In a follow-up to a successful meeting of interventional radiology division chiefs in 2013, the Society of Interventional Radiology (SIR) promoted a session exclusively for the chiefs at SIR‰Ûªs 39th Annual Scientific Meeting 22‰ÛÒ27 March 2014, in San Diego, USA, in which a new professional society, the Association of Chiefs of Interventional Radiology (ACIR) was formed.
The US$415 million cash acquisition is expected to strengthen Boston Scientific‰Ûªs peripheral interventions business and accelerate growth in peripheral atherectomy and thrombectomy categories.
QT Vascular has announced that it has started clinical cases with the Chocolate percutaneous transluminal angioplasty (PTA) balloon catheter in Singapore. Five cases were performed at National University Hospital and Changi General Hospital.
Preliminary observations from the trial were presented at the Global Embolization Symposium and Technologies US (GEST US meeting, 1–4 May, San Francisco, USA) and...
GE Healthcare has announced receiving Food and Drug Administration (FDA) clearance for the Discovery IGS 740, a new rail-free mobile angiography system with a 41x41-cm detector.
Interventional radiology techniques are widely performed and useful in liver metastases from neuroendocrine tumours, but the level of scientific proof is paradoxically low, especially...
The initial clinical experience is to be presented at the Global Embolization Symposium and Technologies US meeting (GEST US,1‰ÛÒ4 May, San Francisco, USA), a press release says.
Two internationally renowned physicians and influencers of opinion, interventional radiologist Johannes Lammer and vascular surgeon Peter Taylor, have retired from active practice. Both Lammer and Taylor retired in early April.
A study presented at the Society of Interventional Radiology‰Ûªs (SIR‰Ûªs) 39th Annual Scientific Meeting (San Diego, USA) by Sam Stuart from Great Ormond Street Hospital for Children, London, UK, suggests that antegrade gastrostomy insertion in infants who are less than 5kg in weight, is technically feasible and safe.
TriVascular, manufacturer of the Ovation Prime Abdominal Stent Graft System has announced the pricing of its initial public offering of 6,500,000 shares of its common stock at a public offering price of US$12.00 per share.
Cook has introduced two new solutions for targeting and treating challenging anatomy ‰ÛÒ the high-flow 0.027‰Û ID Cantata microcatheter and the 0.016‰Û Alight guidewire.
Surefire Medical has announced that the COSY clinical trial (Coiling vs. Surefire infusion system in Y90) showed significant reductions in fluoroscopy time, procedure time,...
Sirtex and Guerbet have announced that the two companies are entering into a collaboration to advance research in primary and secondary metastatic liver cancer.The...
The world’s leading radiologists, oncologists and surgeons will head to Germany in April for the European Conference on International Oncology (ECIO, 23-26 April, Berlin,...
Ultrasound-guided biopsies are more accurate and safer with the Smart Fusion (Toshiba) ultrasound technology, a press release from the company states. Toshiba showcased Smart Fusion at the Society of Interventional Radiology‰Ûªs (SIR) Annual Scientific Meeting (22‰ÛÒ27 March, San Diego, USA).
The final, two-year data from the RENOVA trial that compared the use of the Flair stent-graft (Bard) to the use of percutaneous transluminal angioplasty for treatment of arteriovenous graft stenosis showed that stent grafts proved as safe as angioplasty and more effective.
With the main results of the SYMPLICITY HTN-3 trial due to be presented at the American College of Cardiology’s annual meeting (ACC14, 29‰ÛÒ31 March 2014, Washington, USA), Krishna Rocha-Singh writes about the important factors that need analysis regarding the trial results in particular and renal denervation in general.
The largest study of its kind to date shows that minimally invasive radioembolization may slow metastatic disease progression in liver when no other treatment...
Nonclinical data presented at the Society of Interventional Radiology‰Ûªs (SIR) Annual Scientific Meeting demonstrates immediate occlusion of a large, saccular cerebral aneurysm and full sealing and endothelialisation of the aneurysm neck at one month.
Loping gazelles and talking toys effectively reduce anxiety in patients by tuning out their surroundings, finds new research presented at the Society of Interventional Radiology‰Ûªs 39th Annual Scientific Meeting (23‰ÛÒ27 March, San Diego, USA).
The results from a randomised controlled trial that used the Kiva System (Benvenue) suggest that the vertebral augmentation device offers a new treatment option for individuals with compression fractures.
Ziv J Haskal, Journal of Vascular and Interventional Radiology editor-in-chief, will receive the Leaders in Innovation Award. The foundation will also bestow Young Investigator, Research and Philanthropy Awards during the Society of Interventional Radiology‰Ûªs (SIR) Annual Scientific Meeting (22‰ÛÒ27 March, San Diego, USA).
Hansen has announced that it will present its Magellan Robotic System and its new 6F Robotic Catheter at the Society of Interventional Radiology’s (SIR) Annual Scientific Meeting (23‰ÛÒ27 March, San Diego, USA). The company will be conducting product demonstrations and exhibiting the system at Booth 800.
A study, published in the Journal of Vascular and Interventional Radiology, highlights the benefits of the transradial approach to treat uterine fibroids and investigators find that this technique could be a ‰ÛÏgame changer‰Û for image-guided minimally invasive treatments.
The US FDA has issued clearance allowing a modification of the weight range for the EZ-IO 25mm needle set so that is can be used in patients who are 3kg or over.
Thousands of patients may be facing unnecessary leg amputations, owing to variations in practice around the UK. A new report from the All Party Parliamentary Group on Vascular Disease draws on new data from Freedom of Information requests to NHS Trusts and Clinical Commissioning Groups to draw attention to the variation around the country in amputation rates and implementation of the best clinical practice.
A study that compared the durability of thoracic endovascular aortic repair (TEVAR) in two similar clinical trials, one that used early-generation and another that used later-generation stent-grafts, found a significantly lower freedom from reintervention for patients who received the newer stent grafts.
CeloNova has announced the US FDA 510(k) clearance expanding the indication for Embozene microspheres to include the treatment of uterine fibroids.
The European Congress of Radiology (ECR) saw the launch of the EuroSafe Imaging campaign, an initiative promoting appropriateness in medical imaging, maintaining doses within diagnostic reference levels and emphasising the as low as reasonably achievable (ALARA) principle.
A retrospective study reports that individuals who underwent embolization of the left gastric artery for gastrointestinal bleeding experienced a 7.9% decrease in body weight, three months after the procedure. Could embolization of the left gastric artery be used in the treatment of obesity?
BSD Medical has reported continued sales momentum by Terumo on the distribution of the MicroThermX Microwave Ablation System. BSD‰Ûªs exclusive agreement with Terumo covers distribution of the MicroThermX in more than 100 countries, including Europe, Western Asia and Africa.
The outcomes from our study on the efficacy and safety of percutaneous cryoablation, published recently in CardioVascular and Interventional Radiology, are the result of...
Thomas Nolte, vascular surgeon and director of Vascular Center, Herz und GefaíöÌÙzentrum, Bad Bevensen, Germany, recently commented on the importance of sealing in the endovascular treatment of abdominal aortic aneurysm.
Thomas Zeller, University Heart-Center Freiburg, Bad Krozingen, Germany, told delegates at LINC that drug-eluting balloons may be cost-effective through prevention of target lesion revascularisation at one year of follow-up.
Cordis has announced receiving the CE mark for its Renlane renal denervation for the treatment of patients with resistant hypertension and has completed the first successful cases in Europe.
Data from the PEVAR randomised trial have been published in the Journal of Vascular Surgery and demonstrate a 94% procedural technical success for the totally percutaneous procedure.
Results from the RELINE trial show that the Viabahn covered stent (Gore) conferred significantly better protection against target lesion revascularisation and had a significantly higher primary patency than percutaneous transluminal angioplasty.
Covidien has introduced the HydroFinity hydrophilic guidewire for use in catheter placement and other procedures to treat vascular diseases.
Anna Maria Belli, professor of Interventional Radiology and consultant radiologist, St George‰Ûªs Healthcare NHS Trust, London, UK and CIRSE president 2013‰ÛÒ2015 spoke to Interventional News about the Europe-wide interventional radiology curriculum and syllabus that CIRSE recently presented. The curriculum was created by a task force, chaired by Belli, and covers the specific areas with which a well-trained interventional radiologist should be familiar.
Medtronic has announced the European launch of a new peripheral angioplasty balloon, TOTAL across that targets challenging lesions in the lower-extremity, including below-the-knee arteries associated with critical limb ischaemia.
The most recent ZILVER PTX trial data, presented at the Controversies and Updates in Vascular Surgery (CACVS) congress (23‰ÛÒ25 January 2014, Paris, France), demonstrate sustained positive results for the paclitaxel-eluting stent (Cook Medical) vs. angioplasty or provisional bare metal stent placement in patients with peripheral arterial disease.
One year results from the prospective, multicentre, randomised, core lab-adjudicated FAIR trial comparing drug-eluting balloon to standard percutaneous transluminal angioplasty for the treatment of superficial femoral artery in-stent restenosis showed positive outcomes for the drug-eluting balloon.
Endologix has announced the US launch of its new Vela proximal endograft system, a clinical solution for endovascular repair in a broad range of aortic neck anatomies.
InspireMD has announced that its new CGuard carotid embolic protection system has been successfully implanted in recent procedures, including a patient treated during the 17(th) Annual Symposium on Interventional Cardiology & Angiology held in Hamburg, Germany on 1 February 2014.
Interventional News has learned that the UK CAVA trial, a four-way randomised controlled trial of long-term venous access devices for the delivery of chemotherapy (Ports versus tunnelled central lines versus peripherally inserted central catheters) has begun. The trial seeks to determine which device offers the best outcomes for long-term chemotherapy delivery.
Boston Scientific has announced the US launch and first use of the OffRoad re-entry catheter system. The system provides a new option to treat chronic total occlusions in the femoropopliteal arteries.
WL Gore has announced the Australia and New Zealand launch of an expanded treatment range, including lower profile components for the Gore Excluder AAA Endoprosthesis used to treat abdominal aortic aneurysms.
AtheroMed has announced receiving US FDA approval to market the Phoenix Atherectomy System that allows physicians to continuously remove diseased material as it is debulked from patients with peripheral arterial disease, using a low profile atherectomy catheter.
Trivascular has announced the completion of enrolment in the OVATION post-market registry, a 500-patient, 30-centre European study. The registry evaluates the safety and performance of the Ovation and Ovation Prime abdominal stent graft systems, with patient follow-up out to five years.
Medtronic has received US FDA approval for use of the Valiant Captivia Thoracic Stent Graft System in the treatment of type B aortic dissections.
Investigators from the MORE (Metastatic colorectal cancer liver metastases outcomes after radioembolization) study have released new findings at the American Society of Clinical Oncology’s 2014 Gastrointestinal...
University of SÌ£o Paulo physicians have treated 120 patients and 97% have reported improvement in symptoms and quality of life. Follow-up with patients ranges from three months to more than five years, with an average of 15 months. Symptoms recurred in 14% of patients, leading to re-embolization, surgery or medication therapy.
Medtronic recently announced that its sham-controlled renal denervation study, SYMPLICITY HTN-3, failed to meet its primary efficacy. Now, Covidien has announced that it is "exiting" the OneShot Renal Denervation Program. Interventional News learns from leaders in the field that the watchword is: ‰ÛÏwait for the publication‰Û.
Six-month results from the prospective, single-arm, multicentre, European ESPRIT I trial being presented at the 26th annual International Symposium on Endovascular Therapy (ISET, 18‰ÛÒ22 January, Miami, USA) suggest that the Esprit drug-eluting bioresorbable vascular scaffold (Abbott Vascular) appears to be effective in treating iliac and femoral lesions.
The most recent results of the multicentre, non-randomised, single-arm prospective STROLL trial were presented at the 26th annual International Symposium on Endovascular Therapy (ISET, 18‰ÛÒ22 January, Miami, USA). The trial is studying the safety and efficacy of the S.M.A.R.T. stent (Cordis) in patients with obstructive superficial femoral artery disease.
Cryoablation kills tumours and provides pain relief to patients whose cancer has spread to the bone and soft tissue, suggests research being presented at...
The Clínica Universidad de Navarra (CUN), Pamplona, Spain, recently celebrated its tenth anniversary of using Yttrium-90 (Y-90) microsphere radioembolization for the treatment of liver...
A prospective single-arm, five-year study has found that CT-guided percutaneous cryoablation for renal cell carcinoma offers very high efficacy, approaching that of the gold...
Hepatic Oncology is published by Future Medicine Ltd, and joins its portfolio of oncology journals providing healthcare practitioners and research professionals with a unique...
The Department of Pediatric Radiology at Texas Children‰Ûªs Hospital has announced that Kamlesh U Kukreja has been named the new chief of Interventional Radiology. Kukreja, whose appointment was effective 1 January has also been appointed as assistant professor of Radiology at Baylor College of Medicine (BCM).
Medtronic‰Ûªs first blinded, randomised, controlled renal denervation pivotal trial in the USA fails to meet its primary efficacy endpoint. However, it did meet the primary safety endpoint.
Reverse Medical has announced receiving CE mark approval for the Barrel vascular reconstruction device and its first use in a European clinical case. The Barrel vascular reconstruction device is intended for use with occlusive devices in the treatment of intracranial aneurysms.
Charles T Dotter was an extraordinary man with a creative, innovative mind and a great capacity for developing new devices, techniques and treatments. He radically changed the treatments of vascular diseases and became the father of interventional radiology, writes Josef RÌ¦sch.
16 January 2014 is the 50th anniversary of the first recorded angioplasty. A unique meeting, scheduled to take place in July 2014 (23‰ÛÒ24), in Portland, USA, the birthplace of angioplasty, aims to look at the future of image-guided interventions from all perspectives in the historic anniversary year of Charles T Dotter‰Ûªs pioneering intervention. Interventional News celebrates with a special feature that relives that landmark 1964 event, with an article by John Kaufman
The latest recommendations, jointly issued by the Royal College of Obstetricians and Gynaecologists (RCOG) and the Royal College of Radiologists (RCR), has recently been published and are intended both for the National Health Service and the private sector.
An important opportunity has opened up for interventional oncologists as WCIO leaders take the helm of the E1208 trial. Michael C Soulen writes that...
The new system covers the majority of angiographic procedures and is highly flexible for improved patient access. There is a new heads-up display with on-screen menu a press release from the company says.
The trial evaluates eliminating coiling by using the anti-reflux Surefire Infusion System in radioembolization procedures in liver cancer. Surefire Medical has announced that it has...
The MVP-5 system (Reverse Medical) is indicated to obstruct or reduce the rate of blood flow in the peripheral vasculature, in 3‰ÛÒ5mm vessels. The company also announced the first US clinical case along with the US FDA 510k clearance.
The Fenestrated Anaconda custom AAA Stent Graft System (Vascutek) achieves high procedural success in short-necked abdominal and pararenal aortic aneurysms, according to results from UK and Dutch experiences presented at the VEITHsymposium in November.
Gunnar Tepe told delegates at the VEITHsymposium in November that the XXS trial would compare the results of the Xpert stent (Abbott) with percutaneous transluminal angioplasty in complex lesions of small arteries below the knee in critical limb ischaemia patients.
Following the exclusive distribution agreement that Aquilant Interventional signed with BiO2 Medical (the Texas-based manufacturer of the Angel Catheter) earlier in 2013, the former company has begun acting as distributor of the Angel catheter for the UK and Ireland.
India has a population that is second only to China, so the number of patients who require interventional radiology treatment are in the millions. However, a major challenge that we face in interventional radiology practice in India is to make it available to the many who cannot afford the cost of the hardware necessary for treatment, Mathew Cherian writes.
Boston Scientific has announced receiving US Food and Drug Administration (FDA) clearance and CE mark approval for the Direxion Torqueable Microcatheter, which is designed to suit a range of peripheral embolization procedures.
Researchers from Oxford suggest that augmentation of the preclose technique (using Proglide from Abbott Vascular) with the Angio-Seal vascular closure device (St Jude Medical) is a safe and effective adjunct for haemostasis that increases the success of percutaneous endovascular aneurysm repair.
The first successful implantations have been carried out in Italy and the United Kingdom, providing endovascular repair to iliac arteries.
EndoShape has announced that it has received 510(k) marketing clearance for its Medusa vascular plug. The US Food and Drug Administration cleared the catheter-delivered device for arterial and venous embolization in the peripheral vasculature.
SYMPLICITY HTN-4 to potentially expand access for additional patients at risk for cardiovascular complications related to uncontrolled hypertension.
The global registry is one of a number of clinical studies that make up the broader EVAS Forward clinical programme aimed at establishing clinical and economic evidence for endovascular aneurysm sealing (EVAS).
LEVANT 2, the first clinical trial in the USA to study the use of drug-coated balloons (CR Bard‰Ûªs Lutonix) for femoropopliteal artery disease, found the procedure is promising for safety and efficacy at six months.
An endovascular aortic repair (EVAR) revolution may be here, Andrew Holden, associate professor of Radiology, Auckland City Hospital, Auckland, New Zealand, told delegates at the CIRSE annual meeting (14‰ÛÒ18 September, Barcelona, Spain).
New data presented at the Transcatheter Cardiovascular Therapeutics (TCT) Conference in San Francisco, USA, demonstrate an excellent safety profile for Boston Scientific‰Ûªs renal denervation system.
On 29 October, Terumo Interventional Systems announced the launch of the 0.018‰Û Glidewire Advantage peripheral guidewire during the 25th Annual Transcatheter Cardiovascular Therapeutics (TCT) Conference in San Francisco, USA.
On 21 October, Vascutek issued a Field Safety Notice initiating a voluntary recall of the Anaconda Bifurcate Body Stent Graft System. An issue with a component of the device, the release wire in the delivery system, identified through Vascutek‰Ûªs post-market surveillance system, is currently being investigated.
Guerbet has announced that it has been granted Orphan Drug Designation from the US Food and Drug Administration Office of Orphan Products Development (OOPD)...
Surefire Medical announced the launch of a new, enhanced infusion system‰ÛÓthe Surefire Infusion System mT‰ÛÓdesigned to treat vessels as small as 2mm to 3.5mm in interventional direct-to-target embolization procedures.
Uncontrolled hypertension is not the same as resistant hypertension. Experts at the third UK Symposium on Renal Denervation (16 October, London, UK) urged physicians to universally apply ambulatory blood pressure monitoring in order to help distinguish between the two and work within a multidisciplinary team to suitably select patients before offering the minimally invasive catheter-based procedure.
The MAJESTIC trial, designed to evaluate the safety and performance of the Boston Scientific‰Ûªs peripheral drug-eluting stent system, is projected to enroll 55 patients across 15 centres in Europe, Australia and New Zealand.
Data from the ZILVER PTX randomised controlled trial, presented at the 2013 Vascular Interventional Advances (VIVA) meeting, demonstrates 75% primary patency in the superficial femoral artery at four years for patients treated with Cook Medical‰Ûªs paclitaxel-eluting stent. This compares to 57.9% patency for patients with provisional bare metal stent placement in the study.
David Safely presented the three-year health related quality of life data from the STROLL clinical trial during a late-breaking clinical trials session at the Vascular Interventional Advances (VIVA) 2013 Annual Meeting in Las Vegas, USA.
Interventional News spoke to Tim A Fischell, professor of Medicine, Michigan State University, USA, about the first use of a novel, endovascular approach using chemical neurolysis via periadventitial injection of dehydrated ethanol to perform renal artery denervation. Catheter-based renal denervation is a novel treatment option for patients with resistant arterial hypertension.
NHS England is inviting specialist hospitals to take part in a new, innovative commissioning approach called ‘commissioning through evaluation’, which is aimed at increasing...
The relative anonymity of interventional radiology to medical students and the impact this might have on recruiting medical students has resulted in concerted action from interventional radiology societies, write Nicholson Chadwick, Alok Bhatt and Geogy Vatakencherry.
A review, published in the Journal of Vascular and Interventional Radiology (JVIR) in August 2013, serves as an introduction to personalised oncology concepts and provides a summary of relevant concepts. Nadine Abi-Jaoudeh, lead author on the paper spoke to Interventional News about the implications for interventional radiologists.
Preliminary data presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) annual scientific meeting (Barcelona, Spain) demonstrated that TVA Medical‰Ûªs vascular catheter-based FLEX System can create autogenous arteriovenous fistulas (AV fistulas) for haemodialysis patients with 94% procedural success.
It is now possible for members and non-members to submit abstracts online for the Society of Interventional Radiology‰Ûªs (SIR‰Ûªs) annual scientific meeting, to be held 22‰ÛÒ27 March 2014 in San Diego, USA.
On 24 September, Medtronic announced that the US Food and Drug Administration (FDA) has approved the Complete SE (self-expanding) vascular stent specifically for use in the superficial femoral artery and proximal popliteal artery.
On 23 September, the US Food and Drug Administration issued final guidance for developers of mobile medical applications, or apps, which are software programs that run on mobile communication devices and perform the same functions as traditional medical devices. The guidance outlines the FDA‰Ûªs tailored approach to mobile apps.
AngioDynamics featured its key innovative products and technologies, including the Angiovac cannula and circuit, Bioflo peripherally inserted central catheters, the Nanoknife system, Nevertouch direct...
Paclitaxel-conferring devices, whether stents or balloons, best for long-term results, meta-analysis...
Konstantinos Katsanos told Interventional News: ‰ÛÏSixteen randomised controlled trials (with >2,500 patients) were analysed with a Bayesian probabilistic approach. Immediate technical success proved to be better with use of covered nitinol stents, while paclitaxel-eluting stents and paclitaxel-coated balloons offered the best long-term results with the least future events.‰Û
There are many new directions for research in the field of transarterial chemoembolization (TACE). After the key development of drug-eluting beads, a better understanding of the cellular mechanisms of TACE is mandatory to take the procedure further, writes Alban Denys.
An international prospective, randomised, multicentre trial that compared stenting using SE Astron Pulsar and Pulsar-18 (both from Biotronik) vs. angioplasty alone, failed to show statistically significant improved outcomes for stenting.
Informing patients about the important details of interventional radiology procedures before getting permission to conduct an intervention, is an important task that should be carried out by a specialist, a new study recommends.
Twelve patients who were available for follow-up had good results at one year with the bioconvertible Sentry inferior vena cava filter (Novate), data presented at CIRSE 2013 shows.
The freedom from target lesion revascularisation data, presented by Michael Dake, Stanford, USA, at CIRSE (14‰ÛÒ18 September, Barcelona, Spain) shows that the drug-eluting stent provides longer-term results and reduces re-intervention rates by 45%.
Terumo will showcase BSD‰Ûªs MicroThermx microwave ablation system at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) annual conference.
"This study is important because the most feared, but rare, complication of non-target embolization could be mitigated with the use of cone beam CT. This offers the interventional radiologist an opportunity to identify possible sources of non-target embolization prior to performing the actual procedure," lead author Sandeep Bagla told Interventional News.
Nigel Hacking, consultant radiologist, Southampton University Hospitals NHS Trust, Southampton, UK, spoke to Interventional News about using polyvinyl alcohol foam embolization particles (Cook) for prostatic artery embolization in younger men with benign prostatic hyperplasia.
Eighty eight treatment-resistant hypertension patients were available for 36-month evaluations following treatment with the Symplicity renal denervation system. These 88 patients demonstrated sustained reductions in blood pressure year-over-year with an average reduction of -32/-14mmHg [p<0.01].
Thomas Vogl, Institute of Diagnostic and Interventional Radiology, Goethe University, Frankfurt, spoke at ECIO (19–22 June, Budapest Hungary) about novel lung ablative techniques and...
The third generation ExAblate system, using non-invasive MR-guided focused ultrasound (MRgFUS) is now available for Canadian patients.
Celsion Corporation announced that Ronnie TP Poon, professor of Surgery at the University of Hong Kong and lead Asia Pacific principal investigator for the company’s phase...
For the two-thirds of lung cancer patients with locally advanced or metastatic disease, tumour size is not used currently to predict overall survival times....
The SuperNOVA trial is a global, single-arm, prospective, multicentre trial evaluating the long-term (12 month) safety and effectiveness of the Innova stent system.
Reverse Medical corporation has announced FDA clearance for US commercialisation of their MVP microvascular plus system for peripheral artery embolization, and the first US clinical cases. The MVP system indication for use is to obstruct or reduce the rate of blood flow in the peripheral vasculature.
Data from the multicentre ENRY evaluation of 325 patients, suggest that radioembolization may be a well tolerated and effective option for an increasing population...
Surefire Medical has announced that Gordon McLennan, Cleveland Clinic, USA, and Fred Moeslein, University of Maryland Medical Center, USA, have joined the company’s scientific...
Interventional radiologists can play an important role in managing complications post surgery because surgical re-intervention is always linked with a higher risk of complications. Also, in some procedures, interventional radiologists have the necessary skills and training not just to manage complications after bariatric surgery, but to offer the primary treatment themselves, writes Mario Corona
‰ÛÏCurrently, the treatment of in-stent restenosis remains a difficult and unresolved issue. We wanted to see if the placement of a ‰Ûªtemporary‰Ûª bioabsorbable stent can provide a solution [to this problem], as such stents disappear over time and can no longer induce intimal hyperplasia formation,‰Û Goverde told delegates at EuroPCR.
The new access technique could be used in treating peripheral arterial disease, including for patients with critical limb ischaemia. Cook Medical has completed patient enrolment in a study investigating the approach.
Cook Medical is shipping its Zilver PTX drug-eluting peripheral stent to medical centres in the USA, Japan, Europe and other major markets again. The shipments follow a brief period of unavailability due to a voluntary recall by Cook related to an issue with the stent‰Ûªs delivery catheter that has been resolved.
BTG announced on 30 July that the National Institute for Health and Clinical Excellence (NICE) has issued guidance recommending the use of selective internal...
A prospective study has revealed that cryoneurolysis could be a potential treatment for patients with neuralgia when conventional treatments fail. The minimally invasive treatment at the site of focal neuralgia statistically significantly decreased pain scores in patients.
InSightec announced that its ExAblate system received approval from the Chinese Food and Drug Administration (CFDA) for magnetic resonance-guided focused ultrasound treatment of uterine fibroids.
An abstract presentation during EuroPCR 2013 (21‰ÛÒ24 May, Paris, France) focused on assessing the number and quality of published clinical trials underpinning the wide use of renal denervation in Germany.
A study, published online on 8 July in the Journal of Vascular and Interventional Radiology, found that peripheral interventional radiologists who use CT perfusion imaging for patient selection had good neurologic outcomes when they treated stroke patients.
Abbott has entered into an agreement to purchase IDEV Technologies, according to a press release. Per the terms of the agreement, Abbott will acquire all outstanding equity of IDEV Technologies for US$310 million net of cash and debt.
The Canadian Interventional Radiology Association (CIRA) has recently announced that the Royal College of Physicians and Surgeons of Canada has approved interventional radiology as a subspecialty.
Case reports published in the Journal of Cardiovascular and Interventional Radiology have found that by using the Surefire Infusion System, radioembolization could be successfully...
Outcome data from CASSIA, a ‰ÛÏreal world‰Û registry, demonstrate that carotid artery stenting appears to be safe and effective in terms of clinical outcomes in patients with diabetes and other risk factors.
Tiago Bilhim, interventional radiology, Saint Louis Hospital, Lisbon, Portugal, presented the results of a randomised prospective study which compared 100åµm with 200åµm polyvinyl alcohol particles (PVA) for prostatic artery embolization at the Society of Interventional Radiology Annual Meeting (13‰ÛÒ18 April, New Orleans, USA).
Merit Medical Systems has announced that it has received multiple regulatory approvals from regulatory bodies in the USA, Europe, Japan and China.
Following carotid intervention, the number of detectable diffusion-weight magnetic resonance imaging (DWMRI) lesions is an order of magnitude greater than adverse clinical event (stroke/death). This lends credence to the use of DWMRI as a surrogate endpoint allowing comparisons of interventional strategies in studies with reduced sample size, wrote Sumaira Macdonald.
Royal Philips has announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its AlluraClarity live image guidance system in the USA.
Sirtex Medical and US-based Surefire Medical has announced a sales and marketing partnership to distribute Surefire’s range of innovative infusion systems and specialty catheters for the...
Launched by the Assistance Publique Hôpitaux de Paris, France, in December 2011, SARAH (Sorafenib versus radioembolization in advanced hepatocellular carcinoma), a French national collaborative randomised controlled trial...
The Society of Interventional Radiology has announced, on 11 June 2013, the release of ‰ÛÏUpdates in interventional radiology 2013,‰Û which is intended to be a concise reference of the current literature most relevant to the specialty.
The Alliance for MRI announced on 11 June that the European Parliament has approved derogation for magnetic resonance imaging (MRI) in its draft report on the revised directive on protecting workers from exposure to electromagnetic fields.
Investigators from Thomas Jefferson University published a study in the February edition of the Journal of Vascular and Interventional Radiology comparing the incidence of progression of hepatocellular carcinoma when treated with either doxorubicin-eluting beads or ethiodol-based regimens using either cisplatin/adriamycin/mitomycin-c (CAM) or adriamycin alone. Daniel B Brown writes about the outcomes and implications of this study.
According to a company release, the first patient has been enrolled in the Lutonix below-the-knee clinical trial which is intended to compare the safety and effectiveness of the Lutonix 014 drug-coated percutaneous transluminal angioplasty dilation catheter vs. a standard angioplasty balloon for the treatment of critical limb ischaemia.
St Jude Medical has announced that the US Food and Drug Administration (FDA) has approved the initiation of the EnligHTN IV Renal Denervation Study.
ArtVentive Medical Group has announced that it has received the CE mark for the ArtVentive EOS peripheral vascular endoluminal occlusion system.
Results from a large randomised trial supported the use of a 180 watt laser therapy as a viable treatment option for benign prostatic hyperplasia.
According to a press release, UroLift met all of its study endpoints in the LIFT multicentre, randomised controlled study. The LIFT study demonstrated that patients experienced rapid and significant symptom relief, improved urinary flow rates, preserved sexual function and that UroLift is well tolerated under local anaesthesia.
Reverse Medical announced on 14 May 2013 the initial clinical use of their MVP microvascular plug system for peripheral artery embolization. The device has been granted CE mark approval to obstruct or reduce the rate of blood flow in the peripheral vasculature.
SonaCare Medical, at the American Urological Association‰Ûªs Annual Meeting (4‰ÛÒ8 May 2013, San Diego, USA) launched their high-intensity focused ultrasound surgical ablation system‰ÛÓSonatherm.
The James Cook University Hospital, part of South Tees Hospitals NHS Foundation Trust has ordered an Artis zee multi-purpose interventional imaging system and three Ysio digital X-ray systems from Siemens Healthcare.
Open access publisher BioMed Central has announced the launch of the Journal of Therapeutic Ultrasound, which is in partnership with the Focused Ultrasound Foundation and the International Society for Therapeutic Ultrasound.
Detailed experiences of stereotactic ablative body radiotherapy (SABR) treatments using Varian’s TrueBeam medical linear accelerator and Calypso “GPS for the Body” tumour-tracking technology were...
Medtronic‰Ûªs Valiant Mona LSA branch stent graft system for the repair of thoracic aortic aneurysms has been tested in the USA as part of the US Food and Drug Administration (FDA) initiative to encourage early-stage clinical research for new devices in the USA.
The study, which was presented at the European Society for Radiotherapy and Oncology (ESTRO) 19 to 23 April 2013, Geneva, Switzerland, used the latest cost effectiveness model...
PVA foam embolization particles to treat benign prostatic hyperplasia from Cook Medical have received the CE mark, according to a press release. The product was showcased at the Global Embolization Symposium and Technologies (GEST) 1‰ÛÒ4 May 2013 in Prague, Czech Republic.
Echosens has announced that FibroScan device received 510(k) clearance from the US Food and Drug Administration (FDA) and is preparing to market its technology in the USA.
In a presentation of early data from a prostatic artery embolization cohort, Sandeep Bagla, Inova Alexandria Hospital, Alexandria, USA, spoke about prostatic artery embolization as a favourable alternative to current treatments.
The RENOVA (Post-approval study for the Flair endovascular stent graft) results showed that stent grafts keep access sites open significantly longer in haemodialysis patients than angioplasty alone, according to a presentation at the Society of Interventional Radiology‰Ûªs Annual Meeting.
David N Tran, UCSF, San Francisco, USA, spoke on the topic of chemoembolization at the Society of Interventional Radiology‰Ûªs Annual Meeting (13‰öÕ18 April 2013, New Orleans, USA), he discussed transcatheter arterial chemoembolization in liver transplant candidates with and without marginal hepatic reserve.